Hibiki Kanda

Kusatsu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Initial biomarker testing strategies and clinical outcomes in advanced non-small cell lung cancer.

Initial biomarker testing strategies and clinical outcomes in advanced non-small cell lung cancer.

Journal: iScience

Published: October 02, 2025

Esophageal Bypass Surgery for an Esophagobronchial Fistula Following Palliative Irradiation for Left Main Bronchial Obstruction Caused by Mediastinal Malignant Lymphoma.

Esophageal Bypass Surgery for an Esophagobronchial Fistula Following Palliative Irradiation for Left Main Bronchial Obstruction Caused by Mediastinal Malignant Lymphoma.

Journal: Surgical case reports

Published: April 23, 2025

Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer: A Prospective Exploratory Study.

Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer: A Prospective Exploratory Study.

Journal: Targeted oncology

Published: August 10, 2023

Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum-Etoposide Chemotherapy.

Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum-Etoposide Chemotherapy.

Journal: Drugs & aging

Published: April 17, 2023

Early Tumor Shrinkage as a Predictor of Favorable Treatment Outcomes in Patients With Extensive-Stage SCLC Who Received Programmed Cell Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy: A Prospective Observational Study.

Early Tumor Shrinkage as a Predictor of Favorable Treatment Outcomes in Patients With Extensive-Stage SCLC Who Received Programmed Cell Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy: A Prospective Observational Study.

Journal: JTO clinical and research reports

Published: December 19, 2022

Efficacy and Safety of Programmed Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC: A Prospective Observational Study.

Efficacy and Safety of Programmed Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC: A Prospective Observational Study.

Journal: JTO clinical and research reports

Published: April 04, 2022

Successful treatment of severe bronchiectasis in the elderly using trimethoprim/sulfamethoxazole.

Successful treatment of severe bronchiectasis in the elderly using trimethoprim/sulfamethoxazole.

Journal: Geriatrics & gerontology international

Published: April 05, 2013

Pulmonary actinomycosis caused by Actinomyces cardiffensis.

Pulmonary actinomycosis caused by Actinomyces cardiffensis.

Journal: Internal medicine (Tokyo, Japan)

Published: October 16, 2012

Evaluation of the efficacy and safety of biapenem against pneumonia in the elderly and a study on its pharmacokinetics.

Evaluation of the efficacy and safety of biapenem against pneumonia in the elderly and a study on its pharmacokinetics.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: May 24, 2012

A retrospective analysis comparing the safety and efficacy of chemotherapy in elderly and non-elderly non-small-cell lung cancer patients.

A retrospective analysis comparing the safety and efficacy of chemotherapy in elderly and non-elderly non-small-cell lung cancer patients.

Journal: Geriatrics & gerontology international

Published: January 12, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026